- Home
- OM
as 09-12-2025 4:00pm EST
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
| Founded: | 2003 | Country: | United States |
| Employees: | N/A | City: | SAN JOSE |
| Market Cap: | 247.1M | IPO Year: | 2020 |
| Target Price: | $22.00 | AVG Volume (30 days): | 156.6K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -12.30 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.85 - $25.35 | Next Earning Date: | 11-05-2025 |
| Revenue: | $119,304,000 | Revenue Growth: | 2.47% |
| Revenue Growth (this year): | 12.37% | Revenue Growth (next year): | 10.52% |
Stock Insider Trading Activity of Outset Medical Inc. (OM)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Nash Marc | OM | SVP Operations and R&D | Aug 15 '25 | Sell | $12.88 | 243 | $3,129.84 | 42,898 | |
| Trigg Leslie | OM | Chair and CEO | Aug 15 '25 | Sell | $12.88 | 904 | $11,643.52 | 122,328 | |
| Brottem John L. | OM | General Counsel | Aug 15 '25 | Sell | $12.88 | 383 | $4,933.04 | 46,883 |
Latest Outset Medical Inc. News
OM Breaking Stock News: Dive into OM Ticker-Specific Updates for Smart Investing
Zacks
3 months ago
Strength Seen in Outset Medical (OM): Can Its 15.0% Jump Turn into More Strength?
GlobeNewswire
3 months ago
Outset Medical to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
MT Newswires
3 months ago
TD Cowen Adjusts Price Target on Outset Medical to $25 From $15, Maintains Buy Rating
MT Newswires
3 months ago
Outset Medical Names Renee Gaeta as CFO
GlobeNewswire
3 months ago
Outset Medical Appoints Renee Gaeta as Chief Financial Officer
MT Newswires
4 months ago
RBC Raises Price Target on Outset Medical to $21 From $14, Keeps Sector Perform Rating
GlobeNewswire
4 months ago
Outset Medical Appoints Industry Veteran Kevin O’Boyle to its Board of Directors
Simply Wall St.
4 months ago
Outset Medical First Quarter 2025 Earnings: Beats Expectations
Compare OM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OM Outset Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.